X
Roche steps up Merck challenge with first-line NSCLC approval in US
https://pharmaphorum.com/news/roche-continues-merck-challenge-with-first-line-nsclc-approval-in-us/
first-line lung cancer
Roche’s Tecentriq combo extends life in advanced NSCLC
Roche has announced that its phase 3 IMpower130 study met its co-primary endpoints of overall survival and progression-free survival in non-small cell lung cancer (NSCLC).
